Prestige Consumer Healthcare (PBH) Raw Materials (2012 - 2019)
Prestige Consumer Healthcare's (PBH) quarterly Raw Materials came in at $17.1 million in Q1 2019, up 30.28% year-on-year from $13.1 million in Q1 2018, and up 24.65% quarter-over-quarter from $13.7 million in Q3 2018.
Prestige Consumer Healthcare (PBH) Raw Materials (2012 - 2019) Analysis & Trends
Prestige Consumer Healthcare's Raw Materials history runs 8 years deep, the most recent figure standing at $17.1 million for Q1 2019.
- On a quarterly basis, Raw Materials rose 30.28% year-over-year to $17.1 million in Q1 2019; TTM through Mar 2019 was $17.1 million, a 30.28% increase from a year earlier, with the FY2019 full-year figure at $17.1 million, up 30.28% from the prior year.
- Raw Materials grew to $17.1 million in Q1 2019 per PBH's latest filing, from $13.7 million in the prior quarter.
- Across five years, Raw Materials topped out at $17.1 million in Q1 2019 and bottomed at $6.4 million in Q3 2015.
- The 5-year median for Raw Materials is $7.8 million (2015), against an average of $9.5 million.
- Across the five-year window, Raw Materials soared 292.7% in 2015 and retreated 3.95% in 2016, its largest moves.
- Year by year, Raw Materials stood at $8.1 million in 2015, then retreated by 1.89% to $7.9 million in 2016, then gained by 25.68% to $10.0 million in 2017, then jumped by 37.26% to $13.7 million in 2018, then gained by 24.65% to $17.1 million in 2019.
- Per Business Quant, the three latest PBH Raw Materials figures stand at $17.1 million (Q1 2019), $13.7 million (Q3 2018), and $13.1 million (Q1 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 17.08 Mn |
| Sep 30, 2018 | 13.70 Mn |
| Mar 31, 2018 | 13.11 Mn |
| Mar 31, 2017 | 9.98 Mn |
| Dec 31, 2016 | 7.94 Mn |
| Sep 30, 2016 | 7.55 Mn |
| Jun 30, 2016 | 7.44 Mn |
| Mar 31, 2016 | 7.56 Mn |
| Dec 31, 2015 | 8.10 Mn |
| Sep 30, 2015 | 6.43 Mn |
| Jun 30, 2015 | 7.75 Mn |
| Mar 31, 2015 | 7.59 Mn |
| Dec 31, 2014 | 6.91 Mn |
| Sep 30, 2014 | 3.93 Mn |
| Jun 30, 2014 | 1.97 Mn |
| Mar 31, 2014 | 3.10 Mn |
| Dec 31, 2013 | 1.46 Mn |
| Sep 30, 2013 | 1.03 Mn |
| Jun 30, 2013 | 1.16 Mn |
| Mar 31, 2013 | 1.88 Mn |